Enhanced in vivo wound healing efficacy and excellent antibacterial, antifungal, antioxidant and anticancer activities via AgNPs@PCS

Today, wound healing is an important clinical problem that is often affected by microbial infection and not paying attention to this problem can cause irreparable damage to people. Biosynthesis of metal nanoparticles (NPs) has created a huge revolution in the field of nanomedicine due to their non-toxic, biocompatible, and stable characteristics. For this purpose, in this study, Petroselinum crispum seed extract (PCS) was applied to preparation of silver nanoparticles (AgNPs@PCS). The optimization of the silver nanoparticle synthesis involved adjusting the concentration of the silver salt, as well as the time and temperature parameters. After identifying the fabricated nanoparticles by FESEM, XRD, FT-IR, UV–Vis, TEM and EDS, their biological activity (like antibacterial, antifungal, antioxidant, anticancer, and wound treatment) was determined. The green synthesis of AgNPs was confirmed by several characteristics, including the surface plasmon response with a peak around 420 nm, the presence of both regular and heterogeneous sizes in the sample, and the observed color change from a clear solution to a brown color. The antimicrobial properties of the biofabricated AgNPs were investigated against fungal and various bacteria. The anticancer property of AgNPs@PCS was demonstrated by an IC50 value of 200 µg/ml after a 24-hour exposure on the MCF-7 cell line. Also, a dose-dependent antioxidant performance of AgNPs was found against the DPPH free radical. Histopathological evaluations of AgNPs@PCS ointment illustrated significant decrease in inflammatory cells. The results showed that vaseline ointment containing AgNPs@PCS prevented inflammation in the wound area and increased the number of fibroblast cells, which led to accelerated wound healing. Furthermore, in-vivo investigation showed the higher percentage of wound closure on days 7 and 14 was than the control group (Vaseline). Interestingly, the wound was completely closed after 21 days. Thus, we concluded that Petroselinum crispum-mediated silver nanoparticles show potential biological activity which can be used as nano-drug in clinical treatment

Clinical Breast Cancer Registry of IR. Iran (CBCR-IR):Study Protocol and First Results

BACKGROUND: Breast cancer (BC), as a significant global health problem, is the most common cancer in women. Despite the importance of clinical cancer registries in improving the quality of cancer care and cancer research, there are few reports on them from low- and middle-income countries. We established a multicenter clinical breast cancer registry in Iran (CBCR-IR) to collect data on BC cases, the pattern of care, and the quality-of-care indicators in different hospitals across the country.METHODS: We established a clinical cancer registry in 12 provinces of Iran. We defined the organizational structure, developed minimal data sets and data dictionaries, verified data sources and registration processes, and developed the necessary registry software. During this registry, we studied the clinical characteristics and outcomes of patients with cancer who were admitted from 2014 onwards.RESULTS: We registered 13086 BC cases (7874 eligible cases) between 1.1.2014 and 1.1.2022. Core needle biopsy from the tumor (61.25%) and diagnostic mammography (68.78%) were the two most commonly used diagnostic methods. Stage distribution was 2.03% carcinoma in situ, 12% stage I, 44.65% stage II, 21.32% stage III, and 4.61% stage IV; stage information was missing in 1532 patients (19.46%). Surgery (95.01%) and chemotherapy (79.65%) were the most common treatments for all patients.CONCLUSION: The information provided by this registry can be used to evaluate and improve the quality of care for BC patients. It will be scaled up to the national level as an important resource for measuring quality of care and conducting clinical cancer research in Iran.</p